BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 28638091)

  • 1. The cannabinoid ligand LH-21 reduces anxiety and improves glucose handling in diet-induced obese pre-diabetic mice.
    Romero-Zerbo SY; Ruz-Maldonado I; Espinosa-Jiménez V; Rafacho A; Gómez-Conde AI; Sánchez-Salido L; Cobo-Vuilleumier N; Gauthier BR; Tinahones FJ; Persaud SJ; Bermúdez-Silva FJ
    Sci Rep; 2017 Jun; 7(1):3946. PubMed ID: 28638091
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anti-obesity efficacy of LH-21, a cannabinoid CB(1) receptor antagonist with poor brain penetration, in diet-induced obese rats.
    Alonso M; Serrano A; Vida M; Crespillo A; Hernandez-Folgado L; Jagerovic N; Goya P; Reyes-Cabello C; Perez-Valero V; Decara J; Macías-González M; Bermúdez-Silva FJ; Suárez J; Rodríguez de Fonseca F; Pavón FJ
    Br J Pharmacol; 2012 Apr; 165(7):2274-91. PubMed ID: 21951309
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Atypical Cannabinoid Abn-CBD Reduces Inflammation and Protects Liver, Pancreas, and Adipose Tissue in a Mouse Model of Prediabetes and Non-alcoholic Fatty Liver Disease.
    Romero-Zerbo SY; García-Fernández M; Espinosa-Jiménez V; Pozo-Morales M; Escamilla-Sánchez A; Sánchez-Salido L; Lara E; Cobo-Vuilleumier N; Rafacho A; Olveira G; Rojo-Martínez G; Gauthier BR; González-Mariscal I; Bermúdez-Silva FJ
    Front Endocrinol (Lausanne); 2020; 11():103. PubMed ID: 32210914
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel CB1 receptor antagonist BAR-1 modifies pancreatic islet function and clinical parameters in prediabetic and diabetic mice.
    Nava-Molina L; Uchida-Fuentes T; Ramos-Tovar H; Fregoso-Padilla M; Rodríguez-Monroy MA; Vega AV; Navarrete-Vázquez G; Andrade-Jorge E; Villalobos-Molina R; Ortiz-Ortega R; Vilches-Flores A
    Nutr Diabetes; 2020 Mar; 10(1):7. PubMed ID: 32132523
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Central versus peripheral antagonism of cannabinoid CB1 receptor in obesity: effects of LH-21, a peripherally acting neutral cannabinoid receptor antagonist, in Zucker rats.
    Pavón FJ; Serrano A; Pérez-Valero V; Jagerovic N; Hernández-Folgado L; Bermúdez-Silva FJ; Macías M; Goya P; de Fonseca FR
    J Neuroendocrinol; 2008 May; 20 Suppl 1():116-23. PubMed ID: 18426510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cannabinoid receptor 1 (CB1) antagonism enhances glucose utilisation and activates brown adipose tissue in diet-induced obese mice.
    Bajzer M; Olivieri M; Haas MK; Pfluger PT; Magrisso IJ; Foster MT; Tschöp MH; Krawczewski-Carhuatanta KA; Cota D; Obici S
    Diabetologia; 2011 Dec; 54(12):3121-31. PubMed ID: 21987346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metallothionein 1 negatively regulates glucose-stimulated insulin secretion and is differentially expressed in conditions of beta cell compensation and failure in mice and humans.
    Bensellam M; Shi YC; Chan JY; Laybutt DR; Chae H; Abou-Samra M; Pappas EG; Thomas HE; Gilon P; Jonas JC
    Diabetologia; 2019 Dec; 62(12):2273-2286. PubMed ID: 31624901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity.
    Ravinet Trillou C; Delgorge C; Menet C; Arnone M; Soubrié P
    Int J Obes Relat Metab Disord; 2004 Apr; 28(4):640-8. PubMed ID: 14770190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence.
    Ohneda M; Inman LR; Unger RH
    Diabetologia; 1995 Feb; 38(2):173-9. PubMed ID: 7713311
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of adiponectin in the metabolic effects of cannabinoid type 1 receptor blockade in mice with diet-induced obesity.
    Tam J; Godlewski G; Earley BJ; Zhou L; Jourdan T; Szanda G; Cinar R; Kunos G
    Am J Physiol Endocrinol Metab; 2014 Feb; 306(4):E457-68. PubMed ID: 24381003
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cannabinoid receptor 1 antagonist treatment induces glucagon release and shows an additive therapeutic effect with GLP-1 agonist in diet-induced obese mice.
    Patel KN; Joharapurkar AA; Patel V; Kshirsagar SG; Bahekar R; Srivastava BK; Jain MR
    Can J Physiol Pharmacol; 2014 Dec; 92(12):975-83. PubMed ID: 25361428
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psoriatic skin inflammation induces a pre-diabetic phenotype via the endocrine actions of skin secretome.
    Evans EA; Sayers SR; Kodji X; Xia Y; Shaikh M; Rizvi A; Frame J; Brain SD; Philpott MP; Hannen RF; Caton PW
    Mol Metab; 2020 Nov; 41():101047. PubMed ID: 32599074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pancreatic AT1aR Deficiency Decreases Insulin Secretion in Obese C57BL/6 Mice.
    Shoemaker R; AlSiraj Y; Chen J; Cassis LA
    Am J Hypertens; 2019 May; 32(6):597-604. PubMed ID: 30903169
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacological evaluation of LH-21, a newly discovered molecule that binds to cannabinoid CB1 receptor.
    Chen RZ; Frassetto A; Lao JZ; Huang RR; Xiao JC; Clements MJ; Walsh TF; Hale JJ; Wang J; Tong X; Fong TM
    Eur J Pharmacol; 2008 Apr; 584(2-3):338-42. PubMed ID: 18336811
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Coordinated improvement in glucose tolerance, liver steatosis and obesity-associated inflammation by cannabinoid 1 receptor antagonism in fat Aussie mice.
    Bell-Anderson KS; Aouad L; Williams H; Sanz FR; Phuyal J; Larter CZ; Farrell GC; Caterson ID
    Int J Obes (Lond); 2011 Dec; 35(12):1539-48. PubMed ID: 21386801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monoacylglycerol lipase deficiency affects diet-induced obesity, fat absorption, and feeding behavior in CB
    Yoshida K; Kita Y; Tokuoka SM; Hamano F; Yamazaki M; Sakimura K; Kano M; Shimizu T
    FASEB J; 2019 Feb; 33(2):2484-2497. PubMed ID: 30265576
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phlorizin Supplementation Attenuates Obesity, Inflammation, and Hyperglycemia in Diet-Induced Obese Mice Fed a High-Fat Diet.
    Shin SK; Cho SJ; Jung UJ; Ryu R; Choi MS
    Nutrients; 2016 Feb; 8(2):92. PubMed ID: 26891322
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the cannabinoid receptor-1 antagonist rimonabant on inflammation in mice with diet-induced obesity.
    Wang Q; Perrard XD; Perrard JL; Mansoori A; Smith CW; Ballantyne CM; Wu H
    Obesity (Silver Spring); 2011 Mar; 19(3):505-13. PubMed ID: 20885384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-fat diet induces early-onset diabetes in heterozygous Pax6 mutant mice.
    Chen Y; Feng R; Wang H; Wei R; Yang J; Wang L; Wang H; Zhang L; Hong TP; Wen J
    Diabetes Metab Res Rev; 2014 Sep; 30(6):467-75. PubMed ID: 24925705
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual inhibition of cannabinoid CB
    Udi S; Hinden L; Ahmad M; Drori A; Iyer MR; Cinar R; Herman-Edelstein M; Tam J
    Br J Pharmacol; 2020 Jan; 177(1):110-127. PubMed ID: 31454063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.